Butoconazole NitrateOther Names: Gynazole, Gynazole-1 Drug Class: Opportunistic Infections and Coinfections
What is butoconazole nitrate?
Butoconazole nitrate is anprescription medicine approved by the U.S. (FDA) for the treatment of vulvovaginal , which is an of the female vulva and vagina. Vulvovaginal candidiasis is a type of candidiasis.
Vulvovaginal candidiasis is an What is an Opportunistic Infection? fact sheet.(OI) of HIV. An OI is an infection that occurs more frequently or is more severe in people with weakened immune systems—such as people with HIV—than in people with healthy immune systems. To learn more about OIs, read the
How is butoconazole nitrate used in people with HIV?
The Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents include recommendations on the use of butoconazole nitrate to treat uncomplicated vulvovaginal candidiasis.
This may not include all of the uses of butoconazole nitrate in people with HIV that are recommended in the guidelines. Some recommended uses, such as uses in certain rare circumstances, may have been omitted.
What should I tell my health care provider before using butoconazole nitrate?
Before using butoconazole nitrate, tell your health care provider:
- If you are allergic to butoconazole nitrate or any other medicines.
- About any medical conditions you have or have had.
- About anything that could affect your ability to use butoconazole nitrate, such as difficulty with applying a cream to the affected area or trouble remembering a scheduled .
- If you are pregnant or plan to become pregnant. Whether butoconazole nitrate can harm an unborn baby is unknown. Butoconazole nitrate should be used during pregnancy only if the potential benefit justifies the potential risk to the . Talk to your health care provider about possible risks with taking butoconazole nitrate when pregnant.
- If you are breastfeeding or plan to breastfeed. Do not breastfeed if you have HIV.
- About other prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Butoconazole nitrate may affect the way other medicines or products work, and other medicines or products may affect how butoconazole nitrate works. Ask your health care provider if there are interactions between butoconazole nitrate and the other medicines you take.
Ask your health care provider about possible side effects from butoconazole nitrate. Your health care provider will tell you what to do if you have side effects.
How should I use butoconazole nitrate?
Use butoconazole nitrate according to your health care provider’s instructions. Your health care provider will tell you how much butoconazole nitrate to use and when to use it. Before you start using butoconazole nitrate and each time you get a refill, read any printed information that comes with your medicine.
How should butoconazole nitrate be stored?
- Store butoconazole nitrate cream at room temperature, 68°F to 77°F (20°C to 25°C). Avoid heat above 86°F (30°C).
- Keep butoconazole nitrate in the container that it came in and keep the container tightly closed.
- Do not use butoconazole nitrate if the original seal over the applicator opening is broken or missing.
- Throw away butoconazole nitrate that is no longer needed or expired (out of date). Follow FDA guidelines on how to safely dispose of unused medicine.
- Keep butoconazole nitrate and all medicines out of reach of children.
Where can I find more information about butoconazole nitrate?
More information about butoconazole nitrate is available:
- Recommendations on the HIV-related use of butoconazole nitrate, from the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents, prepared by the , the , and the HIV Medicine Association of the Diseases Society of America
- Butoconazole nitrate-related research studies, from the AIDSinfo database of study summaries
The above Patient Version drug summary is based on the following FDA label(s): Cream.
Last Reviewed: March 20, 2019